Last Updated:
Name Designation Appointment Date Status
Nitin Joshi

Appointed as Director since August 2022

Director 04-Aug-2022 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Amit Suneja

Appointed as Director since August 2022

Director 08-Aug-2022 Current
Rajeev Naithani

Appointed as Director since August 2022

Director 04-Aug-2022 Current

People Timeline

Explore the timeline of key personnel in Noshi India Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address A 227/A , Gali No-9, West Vinod Nagar Mandawali, Delhi Delhi, 110092, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110092
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Noshi India Pharmaceuticals Private Limited?
You can contact Noshi India Pharmaceuticals Private Limited through their registered address at A 227/A , Gali No-9, West Vinod Nagar Mandawali, Delhi Delhi, 110092, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Noshi India Pharmaceuticals Private Limited?
The current directors of Noshi India Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AMIT SUNEJA
  • NITIN JOSHI
  • RAJEEV NAITHANI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available